Document is current

Article History

Received: 8 November 2024

Accepted: 27 February 2025

First Online: 28 March 2025

Declarations

:

: ASB reports honoraria for presentations, attendance at congresses, travel to courses and congresses, and participation in advisory boards and working groups for AstraZeneca, MSD, Novartis, Pfizer, Lilly, GSK, Pierre Fabre, PharmaAnd, Eisai, and BeiGene, outside the submitted work. JAMR reports honoraria for advisory boards, attendance at congresses, travel to courses and congresses, and participation in speakers’ bureaus for AstraZeneca, Bayer Hispania SL, BeiGene ES, BioSIM, Daiichi Sankyo España SA, Eisai, Eli Lilly, GSK SA, Ipsen, Janssen-Cilag SA, MSD de España SA, Novo Nordisk SA, Organon Salud SL, Pfizer, Roche SA, and Sanofi-Aventis SA. ACG reports advisory roles with Bristol Myers Squibb; participation in speakers’ bureaus for Bristol Myers Squibb, MSD, Pfizer, and Takeda; and travel grants from Bristol Myers Squibb, Merck, MSD, Roche, and Takeda. VMC reports honoraria for advisory boards and participation in working groups for AbbVie, Amgen, AstraZeneca, Merck, Novartis, Pfizer, and Roche. OH reports advisory roles with AstraZeneca, Boehringer Ingelheim, MSD, Pfizer, and Roche; and participation in speakers’ bureaus for AstraZeneca, Bristol Myers Squibb, Eli Lilly, Janssen-Cilag, Merck Serono, MSD, and Roche. BB reports honoraria for presentations, attendance at congresses, travel to courses and congresses, and participation in advisory boards and working groups for Amgen, Astellas, AstraZeneca, Bristol Myers Squibb, Daiichi Sankyo, GSK, Ipsen, Merck, MSD, Novartis, Pfizer, PharmaMar, Roche, Sanofi, Seagen, and Takeda. MEMM reports honoraria for advisory boards, attendance at congresses, travel to courses and congresses, and participation in speakers’ bureaus for Abbvie Spain SLU, Alira Health SA, Amgen, Astellas Pharma SA, AstraZeneca, Aventik Medical SLU, Bayer Hispania SL, B. Braun, BeiGene ES, Boehringer Ingelheim España SA, Bristol Myers Squibb, Daiichi Sankyo España SA, Eisai, Fresenius Kabi España, Gilead Sciences SL, GlaxoSmithKline SA, Immedica, Incyte Biosciences Iberia, Ipsen Pharma SA, Janssen-Cilag SA, Keylates Health Solutions, Kyowa Kirin Farmacéutica SLU, Lilly, Merck Sharp Dohme, Merck SL, Novartis Organon Salud SL, Pfizer SLU, Pharmalex, Pierre Fabre, Roche Farma SA, Sanofi-Aventis SA, Seagen Spain SLU, Laboratorios Servier SL, Takeda Farmaceutica SA, Tesaro Bio Spain, and Vifor Pharma España SL. MM reports honoraria for presentations, attendance at congresses, travel to courses and congresses, and participation in advisory boards and working groups for Amgen, AstraZeneca, Bristol Myers Squibb, MSD, Novartis, Pfizer, Roche, Sanofi, Johnson & Johnson, Immedica, and Takeda, outside the submitted work.

: Not applicable.

: Not applicable.

: Not applicable.